Proed, Inc.

9290 GAITHER RD
Gaithersburg, MD 20877

SBIR Award Summary

Total Number of Awards 18
Total Value of Awards $75K
First Award Date 10/19/93
Most Recent Award Date 01/01/98

Key Personnel

Last Name Name Awards Contact
Berg Patricia E Berg 2
Poola Indira None Poola 1
Hankins W D Hankins 13
Shapiro Steven G Shapiro 1

18 Awards Won

Phase 1 SBIR

Agency: Department of Commerce
Topic: 1998
Budget: 01/01/98 - 12/31/98
PI: Unavailable

Bacterial pathogens in salmonids, such as Renibacterium salmoninarum and Aeromonas salmonicida, are

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/01/97 - 07/31/97

DESCRIPTION (Adapted from applicant's abstract): This project will test the feasibility of using a new gene transfer device to transfect primary human blood progenitors, in vitro. The genetically modified blood precursor cells will be reintroduced by autologous transfusion and permitted to underg...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/96 - 09/29/97

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/96 - 09/29/97

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/96 - 09/30/96

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/96 - 01/31/98

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/96 - 02/28/98

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/95 - 08/31/96

DESCRIPTION: The investigators have discovered and cloned a patentable transcription factor, BP2, which they believe suggests a totally new therapeutic approach to the treatment of sickle cell anemia. BP2 is a repressor of the adult b-globin gene, and they expect that overexpression of BP2 will both decrea...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 06/01/95 - 05/31/97

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/04/95 - 02/29/96

Several years of leukemia research has led the principal investigator to a hypothesis that many cancers remain hormone-dependent, retain the ability to terminally differentiate, and exhibit many normal cell properties. The present study was initiated to exploit one of these properties, namely hormone sensitivity of leukemia cells, in an effo...

Load More